Clinical Laboratory Segment in China Is Thriving

Healthcare spending despite the global recession, expands the clinical lab market in China.

A report by Kalorama Information (Rockville, MD, USA), published in partnership with healthcare IVD market research firm McEvoy & Farmer (Seattle, WA, USA; http://mcevoyandfarmer.com) claims that China's economic growth is estimated by nongovernmental sources to be even higher than the government's official report of about 10%. The country is urbanizing and modernizing and the greater levels of prosperity will enable citizens to seek improved health care and diagnostics.

The Kalorama report forecasts that IVD markets in China will grow to more than $1.5 billion in 2009, making it the world's sixth largest IVD market. The last few years have seen market growth of 15-20%. Approximately 575 new hospitals open in China each year and the government plans to open more than 20,000 health clinics.

In January 2009, China's State Council announced a new US$123 billion healthcare spending program to bring a minimum standard of medical insurance coverage to 90% of entire population. The plan also aims to upgrade hospitals and improve health centers in rural and remote areas. This will result in an increased demand for small instrument placements at thousands of clinics and health centers across the country. China is already the world's number two market for automated IVD instrumentation. Now a significant but completely new market for smaller, more robust instrumentation is emerging.

Kalorama Information is a provider of market research reports for diagnostics, pharmaceutics, medical devices, biotechnology and healthcare. McEvoy and Farmer focus on a single sector of the economy--the IVD marketplace. The company specializes in the emerging markets of Asia and Latin America.

Related Links:
Kalorama Information
McEvoy & Farmer